Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Issued (2022 - 2025)

Prokidney (PROK) has disclosed Shares Issued for 3 consecutive years, with $7.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued rose 105.08% to $7.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.6 million, a 101.7% increase, with the full-year FY2024 number at $144.3 million, changed N/A from a year prior.
  • Shares Issued was $7.1 million for Q3 2025 at Prokidney, down from $144.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $144.3 million in Q4 2024 to a low of -$542.5 million in Q4 2022.
  • A 3-year average of -$132.7 million and a median of -$66.4 million in 2024 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 105.08% in 2025; the steepest drop was 105.08% in 2025.
  • Prokidney's Shares Issued stood at -$542.5 million in 2022, then skyrocketed by 126.6% to $144.3 million in 2024, then plummeted by 95.08% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Shares Issued are $7.1 million (Q3 2025), $144.3 million (Q4 2024), and -$139.9 million (Q3 2024).